Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2014) 35 P807 | DOI: 10.1530/endoabs.35.P807

ECE2014 Poster Presentations Paediatric endocrinology (33 abstracts)

Usefulness of ACTH stimulation in the differential diagnosis of precocious pubarche

Maria Joana Santos 1 , Daniela Amaral 2 , Catarina Limbert 2 , Rosa Pina 2 & Lurdes Lopes 2


1Endocrinology Department, Hospital de Braga, Braga, Portugal; 2Pediatric Endocrinology Unit, Pediatrics Department, Hospital Dona Estefânia, Centro Hospitalar Lisboa Central, Lisboa, Portugal.


Introduction: Nonclassical congenital adrenal hyperplasia (NCCAH) is caused by reduced 21-hydroxylase activity, leading to excessive adrenal androgens and premature pubarche (PP); idiopathic PP (IPP) is its main differential diagnosis. The gold standard for the differential diagnosis is ACTH stimulation test (ST); this test also estimates the adrenal cortisol reserve in NCCAH patients.

Objectives: To compare the clinical characteristics and baseline hormonal profile of patients with PP; to determine the importance of ST in the differential diagnosis between IPP and NCCAH and in the evaluation of the adrenal production of cortisol.

Methods: Retrospective study of patients with PP starting after 2 years of age who underwent ST.

Results: 43 patients were included; median age at diagnosis was 7.5 years (range: 3.5–9.4), 37 (86.0%) were females. After ST, 37 (86.0%) were classified as IPP and 6 (14.0%) as NCCAH. No significant differences could be found in the clinical characteristics and baseline determination of ACTH, cortisol, and adrenal androgens between the groups. Both basal and stimulated 17-OHP levels were significantly higher (P=0.001 and P<0.001 respectively) in NCCAH patients (basal: 4.62±3.70 ng/ml (0.80–10.50); stimulated: 35.41±24.87 ng/ml (12.0–80.2)) than IPP patients (basal: 1.04±0.77 ng/ml (0.22–3.80); stimulated: 4.18±1.71 ng/ml (1.0–8.96)). Nevertheless, the proposed cut-off level (<2.0 ng/ml) for the distinction between the groups, did not allow for this in two NCCAH patients that were only diagnosed after ST. Two NCCAH patients (33.3%) had stimulated cortisol levels <18 μg/dl, showing the need for glucocorticoid stress therapy. NCCAH patients with higher initial 17-OHP value had a lower cortisol after stimulation (P=0.004, r=−0.43).

Conclusion: The ST was useful to distinguish between patients with NCCAH and IPP, for no basal 17-OHP level could allow for a definitive differential diagnosis in the individual patient. In some NCCAH cases, it also showed inappropriate cortisol secretion under stress, contributing to the therapeutic decision.

Article tools

My recent searches

No recent searches.